Stockscreener 앱 받기
4.4214
0.00%
0.0036
Ardelyx Inc 주식(ARDX)의 최신 뉴스
What drives Ardelyx Inc. stock priceUnstoppable profit momentum - Autocar Professional
Is Ardelyx Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
What analysts say about Ardelyx Inc. stockFree Capital Allocation Plans - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
5 stocks with growth potential: SOUN, JBL, MNTN, ARDX, RCEL - Markets.com
Ardelyx Announces Q2 2025 Financial Results Conference Call - AInvest
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Globe and Mail
Ardelyx Sets Q2 Earnings Date: Key Financial Updates Expected from Biopharma Innovator - Stock Titan
Ardelyx Inc. Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Lobbying Update: $540,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Wedbush Issues Negative Outlook for Ardelyx Earnings - MarketBeat
This Small-Cap Stock Could 10x By 2030, But It’s Not For The Faint Of Heart - Barchart.com
Wedbush Raises Price Target on Ardelyx to $13 From $11, Keeps Outperform Rating - MarketScreener
Long Term Trading Analysis for (ARDX) - news.stocktradersdaily.com
Jefferies Maintains a Buy Rating on Ardelyx (ARDX) With an $8 Price Target - MSN
Lobbying Update: $50,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
Ardelyx Faces An Uphill Battle Despite Oral Arguments Set In XPHOZAH Appeal (NASDAQ:ARDX) - Seeking Alpha
Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock - Investing.com
Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock By Investing.com - Investing.com Nigeria
Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN
Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT - MSN
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 – ARDX - ACCESS Newswire
Ardelyx amends loan agreement to draw $50 million and secures future options - Investing.com
Ardelyx spike attributed to Xphozah legal update - MSN
Ardelyx stock spike attributed to Xphozah update (ARDX:NASDAQ) - Seeking Alpha
(ARDX) Trading Signals - news.stocktradersdaily.com
A biopharma bolsters patient centricity and trial diversity goals through newly created role - Yahoo Finance
10 Best Healthcare Penny Stocks to Buy According to Analysts - Insider Monkey
Digging for Diamonds in Biotech: Why Insider Buys Signal Opportunity in Nuvation Bio and Ardelyx - AInvest
H.C. Wainwright Initiates Coverage of Ardelyx (ARDX) Stock, Gives Buy - MSN
13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - PR Newswire
Director David Mott Acquires 200,000 Shares of Ardelyx Inc (ARDX) - GuruFocus
Ardelyx Stockholders Approve Equity Plan Amendment - TipRanks
4.15%
0.51%
자본화:
|
볼륨(24시간):